SCHEMBL10748846

SCHEMBL10748846

COc1ccc(C2CN(C(=O)C(F)(F)F)CCc3cc(OC)c(SC)cc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.47
▸ ESR2 Q92731 2/20 0.47
▸ CYP3A4 P08684 2/20 0.43
▸ CYP2D6 P10635 2/20 0.43
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ MTNR1B P49286 1/20 0.40
▸ KDM1A O60341 1/20 0.39
▸ TRPV1 Q8NER1 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ GRIN2C Q14957 1/20 0.38
▸ ABHD6 Q9BV23 1/20 0.38
▸ HSD11B1 P28845 1/20 0.38
▸ PDE4B Q07343 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ TP53 P04637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10746175 0.88 CYP3A4 (0.53) ESR1ESR2CYP3A4CYP2D6MTNR1B
SCHEMBL10744663 0.84 ESR1 (0.49) ESR1ESR2CYP3A4CYP2D6KMT2A
SCHEMBL10345334 0.79 CYP3A4 (0.53) ESR1ESR2CYP3A4CYP2D6MTNR1B
SCHEMBL10746034 0.77 CYP3A4 (0.56) ESR1ESR2CYP3A4CYP2D6MTNR1B
SCHEMBL10748766 0.76 CYP2D6 (0.55) CYP3A4CYP2D6MTNR1BTRPV1CYP2C19
SCHEMBL11266427 0.76 ESR1 (0.43) ESR1ESR2CYP3A4CYP2D6KMT2A
SCHEMBL10743718 0.74 CYP3A4 (0.53) ESR1ESR2CYP3A4CYP2D6MTNR1B
SCHEMBL6716414 0.73 ESR1 (0.67) ESR1ESR2
SCHEMBL10749164 0.73 CYP3A4 (0.52) ESR1ESR2CYP3A4CYP2D6MTNR1B
SCHEMBL10345641 0.73 CYP3A4 (0.52) ESR1ESR2CYP3A4CYP2D6MTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0244088-A2 1-Phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders SMITHKLINE BEECHAM CORPORATION (US) 1987-11-04 — — EP disclosed
Send feedback